Assignee
A&G PHARMACEUTICAL INC
US·16 granted patents·8 pending applications·151 citations·filing 1999–2023
Top patents by PatentIndex Score
24 records- 0190US7815906B2Compositions and methods for restoring sensitivity to treatment with HER2 antagonistsA & G PHARMACEUTICAL INC·Filed 2008·Granted Oct 19, 2010·12 cites·32 claims
- 0289US7368428B2Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosisA & G PHARMACEUTICAL INC·Filed 2004·Granted May 6, 2008·32 cites·7 claims
- 0386US7091047B2Methods and kits for diagnosing tumorigenicityA & G PHARMACEUTICAL INC·Filed 2002·Granted Aug 15, 2006·19 cites·37 claims
- 0486US6824775B288kDa tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 2001·Granted Nov 30, 2004·9 cites·42 claims
- 0584US7674460B2Compositions and methods for restoring sensitivity to treatment with HER2 antagonistsA & G PHARMACEUTICAL INC·Filed 2004·Granted Mar 9, 2010·18 cites·6 claims
- 0684US7411045B2Autocrine growth factor receptor antibodies and methodsA & G PHARMACEUTICAL INC·Filed 2002·Granted Aug 12, 2008·14 cites·24 claims
- 0781US6670183B288kDa tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 2001·Granted Dec 30, 2003·11 cites·10 claims
- 0880US11555074B2Monoclonal antibodies and conjugates against prostaglandin F2 receptor inhibitor and uses thereofA&G PHARMACEUTICAL INC·Filed 2018·Granted Jan 17, 2023·1 cites·15 claims
- 0980US6881548B2Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapyA & G PHARMACEUTICAL INC·Filed 2001·Granted Apr 19, 2005·14 cites·22 claims
- 1077US8007997B2Methods and compositions for inhibiting the growth of hematopoietic malignant cellsA & G PHARMACEUTICAL INC·Filed 2009·Granted Aug 30, 2011·0 cites·6 claims
- 1175US7592318B288kDa tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 2003·Granted Sep 22, 2009·3 cites·11 claims
- 1274US11801287B2Materials and methods for the development of an antigen-specific immune non-responsiveness stateA & G PHARMACEUTICAL INC·Filed 2020·Granted Oct 31, 2023·0 cites·5 claims
- 1371US2024199738A1Monoclonal antibodies and conjugates against prostaglandin f2 receptor inhibitor and uses thereofA & G PHARMACEUTICAL INC·Filed 2022·Application pending·0 cites
- 1470US6720159B188KDA tumorigenic growth factor and antagonistsA & G PHARMACEUTICAL INC·Filed 1999·Granted Apr 13, 2004·14 cites·35 claims
- 1567US2008114070A1Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosisA & G PHARMACEUTICAL INC·Filed 2008·Application pending·0 cites
- 1663US2020000894A1Materials and methods for the development of an antigen-specific immune non-responsiveness stateA & G PHARMACEUTICAL INC·Filed 2019·Application pending·0 cites
- 1763US2025154237A1Fully human monoclonal antibodies against human progranulinA & G PHARMACEUTICAL INC·Filed 2023·Application pending·0 cites
- 1859US7651854B2Methods for increasing the proliferation of B cellsA & G PHARMACEUTICAL INC·Filed 2003·Granted Jan 26, 2010·0 cites·8 claims
- 1959US2011223623A1Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patientsA & G PHARMACEUTICAL INC·Filed 2009·Application pending·0 cites
- 2056US7183384B2Monoclonal antibody 7H11 reactive with human cancerA & G PHARMACEUTICAL INC·Filed 2004·Granted Feb 27, 2007·4 cites·8 claims
- 2156US2016274114A1Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patientsA&G PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 2255US2016354452A1Materials and methods for the development of an antigen-specific immune non-responsiveness stateA&G PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 2352US7560095B2Cancer specific monoclonal antibodiesA & G PHARMACEUTICAL INC·Filed 2004·Granted Jul 14, 2009·0 cites·12 claims
- 2452US2010111928A1Methods and kits for diagnosis tumorgenicityA & G PHARMACEUTICAL INC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when A&G PHARMACEUTICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →